Literature DB >> 8892901

Repression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1.

O Kranenburg1, P Keblusek, A J Van der Eb, A Zantema.   

Abstract

Expression of the gene encoding the cell cycle regulator cyclin D1 is strongly repressed in adenovirus type 5 E1 (Ad5E1)-transformed cells. Since cyclin D1 is a regulator of cell proliferation, modulation of its abundance may affect cell cycle control. Therefore, we studied the importance of cyclin D1 repression for cell transformation by Ad5E1. We found that forced expression of cyclin D1 does not affect the transforming potential of Ad5E1. Similarly, cyclin D1 overexpression did not affect the efficiency of colony formation, the proliferation rate, or the cell cycle distribution of Ad5E1-transformed cell lines, whereas the colony formation of untransformed cell lines was strongly inhibited. Thus, repression of cyclin D1 expression is not required for initiation or maintenance of cell transformation by Ad5E1. In addition, we show that the growth-suppressive effect of cyclin D1 correlates with cyclin D1 binding to cdk4 rather than to proliferating cell nuclear antigen PCNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892901      PMCID: PMC190850     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.

Authors:  H Lovec; A Sewing; F C Lucibello; R Müller; T Möröy
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

2.  Premature p34cdc2 activation required for apoptosis.

Authors:  L Shi; W K Nishioka; J Th'ng; E M Bradbury; D W Litchfield; A H Greenberg
Journal:  Science       Date:  1994-02-25       Impact factor: 47.728

3.  Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.

Authors:  S Bates; D Parry; L Bonetta; K Vousden; C Dickson; G Peters
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

4.  Cyclin D1 expression is regulated by the retinoblastoma protein.

Authors:  H Müller; J Lukas; A Schneider; P Warthoe; J Bartek; M Eilers; M Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

5.  Cyclin D1 is an essential mediator of apoptotic neuronal cell death.

Authors:  O Kranenburg; A J van der Eb; A Zantema
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

6.  Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation.

Authors:  D Spitkovsky; P Steiner; J Lukas; E Lees; M Pagano; A Schulze; S Joswig; D Picard; M Tommasino; M Eilers
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Authors:  M Meyerson; E Harlow
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death.

Authors:  R S Freeman; S Estus; E M Johnson
Journal:  Neuron       Date:  1994-02       Impact factor: 17.173

9.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

Authors:  D Resnitzky; M Gossen; H Bujard; S I Reed
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.

Authors:  J Lukas; H Müller; J Bartkova; D Spitkovsky; A A Kjerulff; P Jansen-Dürr; M Strauss; J Bartek
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

View more
  1 in total

1.  Cyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity.

Authors:  Hajira B Koeller; M Elizabeth Ross; Sara B Glickstein
Journal:  Neurobiol Dis       Date:  2008-05-10       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.